| Murid herpesvirus-4 exploits dendritic cells to infect B cells M Gaspar, JS May, S Sukla, B Frederico, MB Gill, CM Smith, GT Belz, ... PLoS pathogens 7 (11), e1002346, 2011 | 77 | 2011 |
| Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID … H Nath, A Mallick, S Roy, S Sukla, S Biswas Computational and Structural Biotechnology Journal 19, 459-466, 2021 | 44 | 2021 |
| Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests H Nath, A Mallick, S Roy, S Sukla, K Basu, A De, S Biswas Journal of Medical Microbiology 70 (6), 001369, 2021 | 41 | 2021 |
| Mismatch primer-based PCR reveals that helicase–primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during … S Sukla, S Biswas, A Birkmann, P Lischka, H Zimmermann, HJ Field Journal of antimicrobial chemotherapy 65 (7), 1347-1352, 2010 | 40 | 2010 |
| A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to … S Biswas, RN Miguel, S Sukla, HJ Field Journal of general virology 90 (8), 1937-1942, 2009 | 31 | 2009 |
| Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-Antibody detection kits can give false-positive results for both viruses in regions where both … H Nath, A Mallick, S Roy, S Sukla, K Basu, A De, S Biswas MedRxiv, 2020.07. 03.20145797, 2020 | 26 | 2020 |
| Leptomonas seymouri narna-like virus 1 and not leishmaniaviruses detected in kala-azar samples from India S Sukla, S Roy, S Sundar, S Biswas Archives of virology 162 (12), 3827-3835, 2017 | 24 | 2017 |
| Effects of therapy using a helicase–primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant S Sukla, S Biswas, A Birkmann, P Lischka, H Ruebsamen-Schaeff, ... Antiviral research 87 (1), 67-73, 2010 | 23 | 2010 |
| COVID-19 virus infection and transmission are observably less in highly dengue-endemic countries: Is pre-exposure to dengue virus protective against COVID-19 severity and … S Biswas, S Sukla, S Biswas Clin Exp Investig 1 (2), 1-5, 2020 | 18 | 2020 |
| Helicase–primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections S Biswas, S Sukla, HJ Field Future medicinal chemistry 6 (1), 45-55, 2014 | 18 | 2014 |
| In Vitro Anticancer Activity of Methanolic Extract of Justicia adhatoda Leaves with Special Emphasis on Human Breast Cancer Cell Line S Kumar, R Singh, D Dutta, S Chandel, A Bhattacharya, V Ravichandiran, ... Molecules 27 (23), 8222, 2022 | 15 | 2022 |
| Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes … S Biswas, S Sukla, T Goldner, HJ Field, D Kropeit, D Paulsen, A Welbers, ... Antimicrobial agents and chemotherapy 58 (7), 3843-3852, 2014 | 15 | 2014 |
| Effect of butyrophilin gene polymorphism on milk quality traits in crossbred cattle TK Bhattacharya, SS Misra, FD Sheikh, S Sukla, P Kumar, A Sharma Asian-australasian journal of animal sciences 19 (7), 922-926, 2006 | 15 | 2006 |
| Molecular cloning and characterization of buffalo αs1-casein gene: Full Length Research Paper S Sukla, TK Bhattacharya, RT Venkatachalapathy, P Kumar, A Sharma DNA Sequence 18 (5), 334-340, 2007 | 14 | 2007 |
| Characterization of Indian riverine buffaloes by microsatellite markers S Sukla, BR Yadav, TK Bhattacharya Asian-australasian journal of animal sciences 19 (11), 1556-1560, 2006 | 14 | 2006 |
| Cloning and characterization of DGAT1 gene of Riverine buffalo: Full Length Research Paper RT Venkatachalapathy, A Sharma, S Sukla, TK Bhattacharya DNA Sequence 19 (3), 177-184, 2008 | 13 | 2008 |
| Cross‐reactivity of SARS‐CoV‐2 with other pathogens, especially dengue virus: A historical perspective D Dutta, A Ghosh, C Dutta, S Sukla, S Biswas Journal of Medical Virology 95 (2), e28557, 2023 | 12 | 2023 |
| COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test H Nath, A Mallick, S Roy, T Kayal, S Ranjan, S Sengupta, S Sukla, ... International Journal of Infectious Diseases 122, 576-584, 2022 | 12 | 2022 |
| COVID-19 virus infection and transmission are observably less in highly Dengue-endemic countries: Can Dengue vaccines be “repurposed” to prevent COVID-19? S Biswas, S Sukla Preprints, 2020 | 10 | 2020 |
| Differences of ovine butyrophilin gene (exon 8) from its bovine and bubaline counter part TK Bhattacharya, FD Sheikh, S Sukla, P Kumar, A Sharma Small Ruminant Research 69 (1-3), 198-202, 2007 | 10 | 2007 |
